key: cord-0973498-suw5gyg5 authors: Teo, Chiah Shean; Tan, Pik Munn; Shu, Connie Siew Ing; Choo, Zi Xian; Te, Kian Keong title: Challenges and Strategies for implementing Chinese Medicine during COVID-19 in Malaysia date: 2021-10-07 journal: Integr Med Res DOI: 10.1016/j.imr.2021.100783 sha: 6ac614b49f440ca1c6b771167acd650d5245e07c doc_id: 973498 cord_uid: suw5gyg5 BACKGROUND: Implementing Chinese medicine (CM) for COVID-19 in Malaysia is challenging for local CM practitioners. The successful experience of CM in China can only be partially adopted in Malaysia due to differences in the national health care system and legislation, geographical health disparities and cultural diversity. Despite all the challenges, Malaysian CM practitioners have managed to thrive and found a Malaysian CM solution amid COVID-19. METHODS: A literature review was conducted using various databases and gray literature from inception to August 15, 2021, to evaluate the challenges faced by Malaysian CM practitioners and the corresponding strategies in Malaysia's country context during COVID-19. RESULTS: A total of 9 challenges and issues faced by Malaysian CM practitioners during COVID-19 were identified. Their corresponding strategies were further categorized into 3 phases, namely, preparation, development and implementation. The strategies were appraised using the SWOT analysis method, and 17 factors were identified. Strength analysis includes personalized CM prescriptions with online consultations in Malaysia. Limited research input for CM in COVID-19 and the inadequate research capacity of local CM institutions are discussed in threat analysis. CONCLUSION: Various approaches have been implemented by Malaysian CM practitioners to provide safe, qualified and effective CM services for COVID-19 at the community level, aiming to reduce the national health care burden. A public-private partnership initiative can bridge the knowledge gap and optimize the role of CM in the health emergency system. This Malaysian CM solution can provide insights to interested countries to capitalize on the potential contribution of Traditional and Complementary Medicine (T&CM) in the era of COVID-19. The COVID-19 pandemic has affected Malaysia and led to unprecedented economic and public health concerns in the population. 1 As of August 15, 2021, a total of 1,404,899 confirmed cases of COVID-19, 12,510 deaths and 1,145,128 recovered cases have been reported in Malaysia. 2 The first COVID-19 case in Malaysia was reported on January 25, 2020, followed by the detection of the first locally transmitted case on February 5, 2020. 3 The government of Malaysia implemented the Movement Control Order (MCO) on March 18, 2020 and instituted various public health strategies, such as digital contact tracing applications and social distancing measures, to break the chain of transmission. 1, 4 A standard operating procedure (SOP) was introduced for the public in general, and specific SOPs were imposed on different industries. 5 The role of Chinese medicine (CM) in managing the COVID-19 pandemic is widely acknowledged. 6 Reports have shown that deliberate CM intervention measures have successfully helped reduce mortality and deterioration among COVID-19 patients from mild to moderate cases, in addition to maintaining the wellbeing of health care workers. 7 China in particular has demonstrated remarkable epidemic control with CM intervention throughout all phases of COVID-19, from prevention to post-COVID-19 rehabilitation. 8 However, implementing CM for COVID-19 in Malaysia is rather challenging for local CM practitioners. The successful experience of CM for COVID-19 control in China cannot be directly implemented in Malaysia due to differences in the health care system and legislation, geographical health disparities and cultural diversity. The Malaysian national health care system is generally dominated by modern medicine. The Traditional and Complementary Medicine (T&CM) Act 2016 (Act 775), which regulates T&CM practice and practitioners, was gazetted in 2016, and CM is one of the recognized practice areas. 9 According to the enforcement timeline of Act 775, the Ministry of Health Malaysia (MOH) initiated the registration of practitioners in 2021, and it is expected to be completed only by 2024. Therefore, there are no public service schemes for T&CM practitioners and insufficient funding and support for T&CM development at the national level. 9 The unique features of T&CM in Malaysia include highly diversified T&CM practice areas, strong ethnocultural ownership and provision of T&CM dominated by the private sector. 10 Since Malaysia's independence in 1957, CM services have been provided mainly by the private sector at the community level through charitable organizations. Most CM practitioners are well trained to work in communitybased facilities, but few have had the chance to receive training in hospital settings. This training approach is very different compared to the training modality of CM physicians in China, which includes training for both CM and modern medicine. There were also differences in demographic characteristics, attitudes toward traditional medicine, lifestyle factors and cultural practices between the 2 countries. Therefore, China's CM solution can only be partially adopted, and novel approaches must be employed to implement CM during COVID-19 in the Malaysian context. 12 Despite the aforementioned challenges and issues, Malaysian CM practitioners decided to thrive and found a Malaysian CM solution amid COVID-19. This review aimed to evaluate the challenges faced by Malaysian CM practitioners and the strategies to overcome them in the Malaysian context during COVID-19. A literature review was conducted using PubMed, Science Direct, Google Scholar, and the CNKI database and gray literature including guidelines, national protocols, official statements and field updates in 3 languages (English, Chinese and Malay) from inception to August 15, 2021 , to evaluate the challenges faced by Malaysian CM practitioners and the corresponding strategies, focusing on the implementation of CM for COVID-19 in Malaysia. We identified a total of 9 challenges and issues faced by Malaysian CM practitioners during COVID-19 (Table 1) . Their corresponding strategies were further categorized into 3 phases, namely, preparation, development and implementation (Table 2) . To conduct research on the use of CM for COVID-19. The corresponding strategies and approaches have been categorized into three different phases as follows: improve COVID-19-related symptoms for discharged patients (Figure 2 ). Members of the task force then formed the Malaysian Chinese Medical Society of Epidemic Control and Prevention (CMEC) in January 2021 to systematically organize and manage activities carried out by the task force. 12 In MOH's COVID-19 Management Guidelines in Malaysia No. 5/2020, it is clearly stated that all COVID-19 confirmed cases would be clinically managed based on conventional medicine protocols. Patients diagnosed with COVID-19 will either be referred to a designated government hospital or a Low-Risk COVID-19 Quarantine and Treatment Centre for quarantine and treatment. CM practitioners did not have the opportunity to manage COVID-19 patients clinically from the beginning of the outbreak, and much is unknown about the pathogenesis, transmissibility, severity, and other features associated with COVID-19. Hence, the task force has consulted with CM experts abroad to understand COVID-19 from the CM perspective and its clinical application in the management of COVID-19. The task force moderated an online conference, and the experiences shared by CM experts from Wuhan enlightened the task force on how to implement CM epidemic control and prevention activities at the community and hospital levels. Two main approaches of the CM formula were discussed, including a generalized formula (one formula for all) and personalized formula (one formula for one person). The generalized formula approach has the advantage of supplementing qi (vital energy) by administering the same herbal formula to all populations in the affected area in a short period, with the possibility that a certain group of people with weak body constitution may experience adverse reactions such as diarrhea or stomach pain as its drawback. The personalized formula is preferred for hospitalized patients, as it is customized and prescribed according to individual needs. A dialog session on live broadcast and meeting with the delegates from China on managing COVID-19 using CM was also chaired by Malaysia's deputy director general of health. 13 The head of the anti- After The task force collaborated with a CM pharmaceutical company and a university research center to provide herbal drinks for 2 target populations in an urban conurbation, including the general population staying in the red zone and COVID-19 patients discharged from hospitals from March 2020. Malaysian MOH categorizes districts or areas into three zones based on the COVID-19 incidence rate in the past 14 days. Red zones are defined as districts with at least 41 active cases; yellow zones have one to 40 cases, while green zones have no active cases. 24 The general population Malaysia. In addition to providing herbs to the general public, the task force also started a pilot project to provide free herbal drinks to medical staff in February 2021. The online CM service by the task force initially utilized an online survey form. This form collects the demographics, medical history, current complaints, and tongue images of applicants. These data are then manually transferred to a Microsoft Word document by replacing the identifier with a code to protect participants' privacy. An online platform (www.mytcm.my) was developed with an information technology consulting company to encourage the use of CM for the public and to connect all CM practitioners and medicinal halls to ensure smooth herbal delivery. Various protocols and functions have been included to reduce medication errors, such as prescribing and dispensing errors. Due to limited human resources in the task force and the restriction of movement during the MCO, online consultation with herbal postages has become an important method to reach out to the public ( Figure 1 ). As the number of cases rise in Malaysia, the MOH has started the -home quarantine‖ mode whereby patients who test positive but showed no or mild symptoms (under categories 1 and 2) are treated and quarantined at home with strict monitoring by health care workers. 27 In other words, confirmed cases must quarantine at home for 14 days from the day of diagnosis. Consequently, there has been a surge of COVID-19 patients asking for herbal tea for symptomatic relief. This demand has enabled the CMEC to communicate directly with confirmed cases through online consultation and provide herbal drinks/Chinese herbs to relieve symptoms such as cough, diarrhea, sore throat, and headache. As of August 15, 2021, this online platform has delivered herbal tea to approximately 3000 COVID-19 patients in various phases (quarantined at home, hospitalized, and discharged). Council. 30 The CMEC has foreseen that online consultation and telemedicine will be a vital survival mode for the industry to improve patients' accessibility, especially during lockdowns. A hybrid mode of online and onsite consultation SOPs was prepared with the concept of minimal or zero contact (no direct contact with the patient's body or bodily fluids). The proposal for CM services to be integrated into the national The strength (S), weakness (W), opportunity (O) and threat (T) (SWOT) analysis method is one of the analysis methods used for the in-depth analysis of COVID-19 epidemic prevention and control strategies and to formulate relevant strategic planning. 31 We identified 17 factors using SWOT analysis to appraise COVID-19 CM approaches in Malaysia (Table 3) . Based on the SWOT analysis, we chose one factor from the strength and threat analyses S1 and T2 to discuss in more depth. Most countries outside China that use CM in COVID-19 have used generalized herbal formulas (one formula for all) instead of personalized prescriptions ( Table 4 ). The task force utilized online consultations, which strictly abide by 3 out of 4 of the CM diagnosis methods-inspection, listening, and inquiry, but omit pulse palpation. This protocol is in line with the CM principle that states, -CM prioritizes tongue diagnosis in seasonal induced diseases, and pulse is significant in chronic complicated diseases‖. As the course of a seasonal disease is relatively brief but undergoes rapid changes, it can be reflected in patients' CM tongue diagnosis over time. Hence, tongue images taken by patients using their handphones and uploaded to the online platform are clinically significant bases for CM diagnosis together with their medical history and complaints. However, there is also the shortcoming of online consultation, as patients must be familiar with online technologies, for example, smartphones and laptops with stable internet connections. There may be language barriers as well. Any patients with alarming clinical signs that require direct physical examination must be excluded from online consultations and seek medical help in hospitals. Online consultations with personalized CM prescriptions in epidemics will optimize the use of CM by reaching out to a large number of patients with limited time and human resources while ensuring the safety of CM practitioners. formulas or products or those designated as proposed investigational products. First, the proposed product used in a study must be standardized. If a CM product is in the form of a finished product, an investigation brochure (IB) is required with details of the quality control in manufacturing, authenticity/purity of the herbal content (such as HPLC analysis), and its physicochemical properties. All contents of the product must be certified by the manufacturing company and fulfill the predetermined product release specification(s) and quality with no adulteration or added banned ingredients. Second, there must be a safety assessment either in vivo or clinically conducted on the CM product/formula, which covers general/specific toxicity, pharmacodynamics, pharmacokinetics, or absorption, distribution, metabolism, and excretion (ADME) to support any level of product claims of being free from any toxicological effects or drug-herb interactions. For the efficacy, evidence of preclinical and clinical efficacy of the proposed investigational products must be presented. The presented data must be from the same product produced by the same company used in the study and not data from published references that evaluate similar CM formulas or the history of use according to ancient texts. Data pertaining to evidence or quantitative measures (laboratory or imaging evidence or pre-and post-PCR/RTK) are required. In addition, the mechanism of CM for COVID-19 symptom improvement (either antiviral/antioxidant/analgesic/anticholinergic) or the formula for treating any respiratory symptoms involved, not necessarily specific to COVID-19, must also be clarified. Any CM-related research must fulfill the above criteria before obtaining approval from MREC and carrying out a CM COVID-19 clinical study. However, the above measures have overlooked the fact that CM and modern medicines are different medicines with different bases. Lack of national research priorities, the absence of appropriate research methodology and an inadequate local capacity for conducting T&CM research are the root causes of the current situation. Due to the lack of scientific evidence that traditional herbal medicines can treat COVID-19, the director general of MOH Malaysia stated that traditional medicine can only serve as a complementary therapy for patient recovery. 40 The lack of sufficient research has caused CM interventions to be underutilized and to underperform in public health emergencies. With the SWOT analysis of the internal and external environments, we can observe the advantages, disadvantages, opportunities and threats of CM approaches for COVID-19 in Malaysia. Overall, the advantages outweighed the disadvantages, and the opportunities outweighed the threats. Various approaches have been implemented by the CMEC and task force to provide safe, The authors declare that they have no conflicts of interest. None. No ethical approval was required, as this study did not involve human participants or laboratory animals. The review used literature available from databases and online. Malaysia's approach in handling COVID-19 onslaught: Report on the Movement Control Order (MCO) and targeted screening to reduce community infection rate and impact on public health and economy COVID-19 Malaysia Updates The Current Situation of Covid -19 . Ministry of Health Malaysia This Week in Asia COVID-19 outbreak in Malaysia: Actions taken by the Malaysian government Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial Jiang Xia shuttle hospital with Chinese Medicine unique features. National Administratin of Traditional Chinese Medicine website Health Ministry: Enforcement of TCM Act to be carried out in phases. The Star-News website Traditional and Complementary Medicine Division Ministry of Health Malaysia Traditional Chinese herbal medicine at the forefront battle against COVID-19: Clinical experience and scientific basis Location Matters: Geographic Disparities and Impact of Coronavirus Disease RoS Approves Registration of Cmec to Apply Chinese Medicine IN Covid-19 Control: New Straits Times.‖ NST Online. New Straits Times Chinese expert team holds discussions with Malaysian practitioners on TCM against COVID-19 Guangdong Provincial Programm of Traditional Chinese Medicine Treatment of Coronavirus Disease Malaysia International Conference Held Online for Discussion of COVID-19 Prevention and Treatment with Integrated Traditional Chinese and Western Medicine.University Tunku Abdul Rahman website Great Response from 260 citizens joined to Learn Online Skills Online Sharing Session of Malaysian Chinese Medical Society of Epidemic Control and Safety Guideline for CM Personnel in Malaysia (COVID-19) COVID-19)%201st%20ed.%20S.pdf The Chinese Medicine Task Force of Malaysia (COVID-19) and Beijing Tong Ren Tang Global Expert Group for COVID-19 Prevention and Treatment jointly released the -Malaysia Chinese Medicine Guideline (1st trial version)‖. Univeristy Tunku Abdul Rahman website Guangdong Provincial Programm of Traditional Chinese Medicine Treatment of Coronavirus Disease Diagnosis and Treatment Protocol for COVID-19 (Trial Version 7). China Daily Website Annex 2e: Clinical Management of Confirmed COVID-19 Case in Adult and Paediatric Interim Guidance on Duration of Isolation and Precautions for Adults with Covid-19.‖ Centers for Disease Control and Prevention RoS Approves Registration of Cmec to Apply Chinese Medicine IN Covid-19 Control: New Straits Times.‖ NST Online. New Straits Times Management of suspected, probable and confirmed COVID-19 case. Ministry of Health Malaysia Only 10 Listed as Essential SERVICES: New Straits Times.‖ NST Online. New Straits Times National Institutes of Health Ministry of Health. NIH guidelines for conducting research in ministry of health institutions and facilities. National Institutes of Health Ministry of Health Discussion about SOP with Chinese Medicine Associations to reestablish in advance Traditional and Complementary Medicine Blueprint 2018-2027. Traditional and Complementary Medicine Division Ministry of Health Malaysia Traditional Chinese Medicine as a complementary therapy in combat with COVID-19-A review of evidence-based research and clinical practice Telemedicine and the Use of Korean Medicine for Patients With COVID-19 in South Korea: Observational Study China-Philippines Center of Traditional Chinese medicine" was commended by the Chinese Embassy in the Philippines Acupuncture and TCM Practitioners on the COVID-19 World Chinese Medicine Magazine The Potential Roles of Jamu for COVID-19: A Learn from the Traditional Chinese Medicine TCM (Traditional Chinese Medicine) received by Cambodia for treating COVID-19 patients COVID-19 pandemic: stringent measures of Malaysia and implications for other countries Chinese medicine no cure for Covid-19.Malaymail Website